Literature DB >> 21085566

A case of neurotoxic syndrome with the use of long-acting risperidone and subsequent olanzapine and paroxetine.

Rahul S Bharadwaj, Teresa B Slade.   

Abstract

Entities:  

Year:  2010        PMID： 21085566      PMCID： PMC2983453          DOI： 10.4088/PCC.09l00925gre

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  7 in total

Review 1.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

2.  Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion.

Authors:  K Kmieciak-Kołada; W Felińska; Z Stachura; H Majchrzak; Z S Herman
Journal:  Pol J Pharmacol Pharm       Date:  1987 Jan-Feb

3.  Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  D R Thomas; D R Nelson; A M Johnson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Radioreceptor binding profile of the atypical antipsychotic olanzapine.

Authors:  F P Bymaster; D O Calligaro; J F Falcone; R D Marsh; N A Moore; N C Tye; P Seeman; D T Wong
Journal:  Neuropsychopharmacology       Date:  1996-02       Impact factor: 7.853

5.  Toxic serotonin syndrome or neuroleptic malignant syndrome?

Authors:  M Fink
Journal:  Pharmacopsychiatry       Date:  1996-07       Impact factor: 5.788

Review 6.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

7.  The universal field hypothesis of catatonia and neuroleptic malignant syndrome.

Authors:  B T Carroll
Journal:  CNS Spectr       Date:  2000-07       Impact factor: 3.790
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.